The Covid-19 pandemic boosted demand for quick diagnostic testing to unprecedented levels, bringing into focus the crucial role of pathology players in the healthcare ecosystem.
In the News
Following a recent merger, Innoquest Diagnostics is moving forward as one in pursuit of transformative healthcare. Ginny Foo, CEO, gives us the details Writer: Jack
SINGAPORE — Before the pandemic, diagnostic lab Innoquest Diagnostics’ day-to-day operations involved processing medical tests for tumours, allergies and blood samples, among others.
Innoquest_Newsletter Issue 1